Education
William Zellmer talks with Susan Cornell and Curtis Triplitt about SGLT2 inhibitors, one of the newest classes of oral diabetes medications. With an increasing number of both oral and injectable medications, the faculty explore how SGLT2 inhibitors fit into clinical practice. Faculty: Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, Activity Chair Assistant Director of Experiential Education Associate Professor Department of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois Curtis L. Triplitt, Pharm.D., CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas C.E. Credits: This activity is not eligible for continuing education credits.